Pediatrix Medical Group, Inc. (NYSE:MD) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET
Company Participants
Charles Lynch - Senior Vice President, Finance and Strategy
Dr. Jim Swift - Chief Executive Officer
Marc Richards - Chief Financial Officer
Conference Call Participants
Brian Tanquilut - Jefferies
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Medical Group, Inc. Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. later we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions]
As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Charles Lynch. Please go ahead.
Charles Lynch
Thank you, and good morning, everyone. I will quickly read our forward-looking statements and then we will get into the call. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Security Litigation Reform Act of 1995.
These forward-looking statements are based on assumptions and assessments made by Pediatrix management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.
Any forward-looking statements made during this call are made as of today and Pediatrix undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.
Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company’s filings with the SEC, including the sections entitled Risk Factors.
In today’s remarks by management, we will be discussing non-GAAP financial measures. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be found in this morning’s earnings press release, our quarterly reports on Form 10-Q and our annual report on Form 10-K and on our website at www.pediatrix.com.
With that, I will turn the call over to our CEO, Dr. Jim Swift.
Dr. Jim Swift
Thank you, Charlie. Good morning, everyone. Also with me today is Marc Richards, our Chief Financial Officer. Our disappointing results reflected relatively soft patient volumes and persistent practice level cost inflation. We plan to take meaningful steps to address this shortfall since we firmly believe that our current operating results do not reflect the full earnings potential of this great company.